| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/02/2006 | WO2005113511A9 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/02/2006 | WO2005110994A3 Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| 02/02/2006 | WO2005103032A3 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds |
| 02/02/2006 | WO2005103002A3 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds |
| 02/02/2006 | WO2005097203A3 Serum protein conjugates of ion channel modulating compounds and uses thereof |
| 02/02/2006 | WO2005072308A9 Cgrp receptor antagonists |
| 02/02/2006 | US20060025597 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases |
| 02/02/2006 | US20060025589 2-Thiohydantoine derivative compounds and use thereof for the treatment of diabetes |
| 02/02/2006 | US20060025467 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors |
| 02/02/2006 | US20060025461 Triazole derivative |
| 02/02/2006 | US20060025459 Having Asp2 ( beta -secretase, BACE1 or Memapsin) inhibitory activity, for therapy of diseases characterised by elevated beta -amyloid levels or beta -amyloid deposits |
| 02/02/2006 | US20060025454 Prenylation inhibitors and methods of their synthesis and use |
| 02/02/2006 | US20060025452 Method of treating demyelinating diseases or conditions |
| 02/02/2006 | US20060025451 Novel pyrazole compounds as transforming growth factor (TGF) inhibitors |
| 02/02/2006 | US20060025442 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/02/2006 | US20060025441 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 02/02/2006 | US20060025433 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 02/02/2006 | US20060025432 N-[2-[(3-Chloro-2-fluorobenzyl)thio]-6-[(2-hydroxy-1-methylethyl)amino]-4-pyrimidinyl]- 4-morpholinesulfonamide; asthma, antiallergens; rhinitis, chronic obstructive pulmonary disease, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis |
| 02/02/2006 | US20060025425 Benzimidazole and pyridylimidazole derivatives |
| 02/02/2006 | US20060025423 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels |
| 02/02/2006 | US20060025414 Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/02/2006 | US20060025413 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/02/2006 | US20060025412 Enzyme inhibitors as bactericides for infections |
| 02/02/2006 | US20060025410 2,4-Pyrimidinediamine compounds and their uses |
| 02/02/2006 | US20060025409 e.g. N-{2-[3-(3,4-dimethoxy-phenyl)-propyl]-6-morpholin-4-yl-pyrimidin-4-yl}-N'-(1H-indol-3-ylmethylene)-hydrazine; interleukin-12 antagonist; antiinflammatory, antidiabetic agent; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus |
| 02/02/2006 | US20060025407 Succinoylaminobenzodiazepines as inhibitors of Abeta protein production |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060025402 Benzimidazolidinone derivatives as muscarinic agents |
| 02/02/2006 | DE4314721B4 Nicht-wandernde 1-Hydrocarbyloxy-2,2,6,6-tetramethylpiperidin -1,3,5-triazinderivate als Polymerstabilisatoren Non-migratory 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidin -1,3,5-triazine derivatives as polymer stabilizers |
| 02/02/2006 | DE112004000350T5 Organische Verbindung und organisches elektrolumineszierendes Element Organic compound and an organic electroluminescent element |
| 02/02/2006 | DE102004033794A1 Kationische Metallkomplexe als lichtabsorbierende Verbindungen in der Informationsschicht von optischen Datenträgern Cationic metal complexes as light-absorbing compounds in the information layer of optical media |
| 02/02/2006 | CA2574685A1 Quinazolin-4-yl- piperidine and cinnolin-4-yl- piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
| 02/02/2006 | CA2574361A1 1, 3 substituted cycloamino derivatives and their use as histamine-3 receptor antagonists |
| 02/02/2006 | CA2574169A1 New heterocyclic carboxylic acid amide derivatives |
| 02/02/2006 | CA2574167A1 Kynurenic acid amide derivatives as nr2b receptor antagonists |
| 02/02/2006 | CA2574158A1 New benzoyl urea derivatives |
| 02/02/2006 | CA2574155A1 Indole-2 -carboxamidine derivatives as nmda receptor antagonists |
| 02/02/2006 | CA2574148A1 4-benzylidene-piperidine derivatives |
| 02/02/2006 | CA2573366A1 2-(pyridin-2-yl)-pyrimidines and their use for controlling pathogenic fungi |
| 02/02/2006 | CA2572970A1 Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/02/2006 | CA2572833A1 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 02/02/2006 | CA2571424A1 Bisarylurea derivatives useful for inhibiting chk1 |
| 02/02/2006 | CA2571324A1 Heterocycle-substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/02/2006 | CA2571223A1 Quinazoline derivatives |
| 02/02/2006 | CA2570903A1 N-hydroxyamide derivatives and use thereof |
| 02/02/2006 | CA2570688A1 Compounds and methods for treating dyslipidemia |
| 02/02/2006 | CA2570637A1 N-substituted piperidines and their use as pharmaceuticals |
| 02/02/2006 | CA2570634A1 1 (indole-6-carbonyl-d-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine d-tartrate |
| 02/02/2006 | CA2569507A1 Amido compounds and their use as pharmaceuticals |
| 02/01/2006 | EP1621539A1 Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/01/2006 | EP1621537A1 Five-membered heterocyclic derivative |
| 02/01/2006 | EP1621536A1 Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/01/2006 | EP1621535A1 Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/01/2006 | EP1621195A2 The use of pyridinic NK-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 02/01/2006 | EP1620445A2 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/01/2006 | EP1620434A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/01/2006 | EP1620429A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/01/2006 | EP1620428A1 Substituted pyrimidinones and pyrimidinthiones as crf antagonists |
| 02/01/2006 | EP1620427A1 Carboxamide derivatives as anti-diabetic agents |
| 02/01/2006 | EP1620426A1 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 02/01/2006 | EP1620422A2 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 02/01/2006 | EP1620411A2 Inhibitors of akt activity |
| 02/01/2006 | EP1620410A1 Use of derivatives of 2, 4-dihydro- 1,2,4 triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo) |
| 02/01/2006 | EP1620409A1 Quinoxalin-3-one derivatives as orexin receptor antagonists |
| 02/01/2006 | EP1620408A2 Quinazoline compounds |
| 02/01/2006 | EP1620406A2 1,2-diarylimidazoles useful as inhibitors of cox |
| 02/01/2006 | EP1620405A2 Pyrazole-amides and sulfonamides as sodium channel modulators |
| 02/01/2006 | EP1620400A1 Chemical compounds |
| 02/01/2006 | EP1620108A2 Pyrazole-amine compounds useful as kinase inhibitors |
| 02/01/2006 | EP1620102A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 02/01/2006 | EP1131302B1 Substituted 4-amino-2-aryl-cyclopenta [d]pyrimidines, their production and use and pharmaceutical preparations containing the same |
| 02/01/2006 | EP1119563B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 02/01/2006 | EP1080078B1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 02/01/2006 | EP0970057B1 Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof |
| 02/01/2006 | CN1729186A Piperidine derivatives useful as CCR5 antagonists |
| 02/01/2006 | CN1729185A Nobel compounds having selective inhibiting effect at GSK3 |
| 02/01/2006 | CN1729181A Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/01/2006 | CN1729178A N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 02/01/2006 | CN1729176A Tetrahydroquinoline derivatives and their use as FSH receptor modulators |
| 02/01/2006 | CN1729175A Tetrahydroquinoline derivatives |
| 02/01/2006 | CN1729001A 4-anilino quinazoline derivatives for the treatment of abnormal cell growth |
| 02/01/2006 | CN1728999A Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/01/2006 | CN1728997A Amorphous form of esomeprazole salts |
| 02/01/2006 | CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 02/01/2006 | CN1239496C Respiratory syncytial virus replication inhibitors |
| 02/01/2006 | CN1239441C Method for processing asymmetric hydroxylamination and dihydroxylation reaction by use of supported bi-cinchoni alkaloid ligand |
| 01/31/2006 | US6992189 Such as 4-((Z)-(4-bromophenyl)(ethoxyimno)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; for the treatment of AIDS and related HIV infections |
| 01/31/2006 | US6992187 reacting 4,6-dichloro-5-nitropyrimidine with acyclic carboxy amines, then cyclization of the intermediates to form cellular adhesion inhibitors |
| 01/31/2006 | US6992103 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |
| 01/31/2006 | US6992098 A fluorinated compounds, microbiocides, synthesis with chemical intermediates, amidation, debromination, benzylation, oximination |
| 01/31/2006 | US6992097 such as methyl-1-{2-[4-((2R)-2-{2-[(tert-butoxy)carbonylamino]-2-methylpropanoylamino}-3-indol-3-ylpropanoylamino)imidazolyl]-2-phenylacetyl}pyrrolidine-2-carboxylate |
| 01/31/2006 | US6992092 Anti-diabetic agents |
| 01/31/2006 | US6992091 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; antiarthritic agents |
| 01/31/2006 | US6992090 Substituted piperidine compounds and methods of their use |
| 01/31/2006 | US6992087 Substituted aryl 1,4-pyrazine derivatives |
| 01/31/2006 | US6992084 Compounds and methods for modulating CXCR3 function |
| 01/31/2006 | US6992080 For therapy of cancer, inflammation, arthritis, viral diseases, neurodegenerative diseases such as Alzheimer's disease, cardiovascular diseases, and fungal diseases |
| 01/31/2006 | US6992044 Substituted phenyluracils |